Research led by Barts Cancer Institute, Queen Mary University of London, has revealed novel insights into the mechanisms employed by melanoma cells to form tumours at secondary sites around the body. The findings from the study may help to identify new targets to inhibit melanoma spread and guide treatment decisions in the clinic.
Researchers have found that melanoma cells fight anti-cancer drugs by changing their internal skeleton (cytoskeleton) – opening up a new therapeutic route for combating skin and other cancers that develop resistance to treatment.
As the summer months approach and the weather gets warmer, it is important to be aware of the risks associated with prolonged exposure to the sun. This week (6th-12thMay) is Sun Awareness Week, part of a campaign run by the British Association of Dermatologists, which aims to raise awareness of the dangers of overexposure to […]